학술논문
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Document Type
Artikel
Author
Karasik, A; Lanzinger, S; Chia-Hui Tan, E; Yabe, D; Kim, DJ; Sheu, WH; Melzer-Cohen, C; Holl, RW; Ha, KH; Khunti, K; Zaccardi, F; Subramanian, A; Nirantharakumar, K; Nyström, T; Niskanen, L; Linnemann Jensen, M; Hoti, F; Klement, R; Déruaz-Luyet, A; Kyaw, MH; Koeneman, L; Vistisen, D; Carstensen, B; Halvorsen, S; Langslet, G; Fazeli Farsani, S; Patorno, E; Núñez, J
Source
Diabetes & metabolism. 49(2):101418
Subject
Language
English
English
English
ISSN
1878-1780